Landec Corporation Sets Third Quarter Fiscal Year 2016 Conference Call for March 30, 2016 at 8 a.m. PT and Earnings Release Set for March 29, 2016 After Market
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
MENLO PARK, Calif., March 08, 2016 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) will hold a conference call on Wednesday, March 30, 2016 at 8 a.m. Pacific time to discuss its results for the third quarter fiscal 2016. Financial results will be reported for the 2016 fiscal third quarter ended February 28, 2016 after market close on March 29, 2016.
Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.
Date: Wednesday, March 30, 2016Time: 8 a.m. Pacific time (11 a.m. Eastern time) Toll Free Participant Dial-in Number: (866) 814-1914U.S. and International Toll Number: (703) 639-1358Conference ID: 1670124
Webcast: www.Landec.com/earningscallThe webcast will be available for 30 days through April 29, 2016.
A replay of the teleconference will be available for one week until midnight Eastern Time, Wednesday, April 6, 2016.
Toll free replay dial in: 888-266-2081International replay: 703-925-2533 Replay passcode: 1670124
About Landec Corporation
Landec Corporation is a company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec's subsidiary, Apio, has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec's proprietary food packaging technology with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP (current good manufacturing practices) validated manufacturing facility for supplying commercial, clinical and pre-clinical products. Landec will also periodically work with market-leading companies to develop and commercialize differentiated polymer-based products under R&D and royalty agreements. For more information about the company, visit Landec's website at www.landec.com.
CONTACT: Media and Industry Contact: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: Liolios Group, Inc. Matt Glover (949)574-3860 LNDC@liolios.com
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: JPMorgan Assumes Lumentum (LITE) at Neutral
- Finance of America (FOA) Reports Q1 Revenues of $499M
- Eastside Distilling, Inc. (EAST) Tops Q1 EPS by 42c
Create E-mail Alert Related CategoriesPress Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!